华北制药：产品“腺苷钴胺胶囊”取得注册证

Group 1 - The core point of the article is that Huabei Pharmaceutical has received the drug registration certificate for Adenosylcobalamin capsules from the National Medical Products Administration [2] - The revenue composition for Huabei Pharmaceutical in 2024 is as follows: Chemical preparations account for 44.02%, chemical raw materials account for 26.72%, biological preparations account for 16.36%, pharmaceutical intermediates account for 6.23%, and pharmaceutical and other logistics trade account for 4.61% [2]